Enwei Pharmaceuticals: Controlling Shareholder Plans to Transfer 4 Million Shares through Inquiry Pricing

Enwei Pharmaceuticals announced that the company's controlling shareholder, Chengdu Enwei Investment Co., Ltd., plans to transfer 4 million shares through inquiry transfer, accounting for 3.89% of the total share capital of the company and 3.93% of the total share capital after excluding the shares repurchased by the company. The reason for the transfer is the need for funds. This inquiry transfer will not be conducted through centralized bidding or block trading. The transferee shall not transfer the shares acquired through the inquiry transfer within 6 months after the transfer.